Theranostics : Impact Factor & More
eISSN: 1838-7640pISSN: 1838-7640
Open AccessShare this on:
Key Metrics
CiteScore 
16.7
Impact Factor
10 - 15
Scite Index
0.93 5-Year SI
SJR
Q1Medicine (miscellaneous)
SNIP
1.75
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Theranostics
Theranostics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | IVYSPRING INT PUBL |
| Language | English |
| Frequency | Irregular |
| Article Processing Charges | AUD 2500 |
| Publication Time | 12 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Irregular |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Theranostics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Theranostics
Multifunctional nanozyme platforms in central nervous system therapies: from rational design to translational medicine
- 29 Jul 2026
- Theranostics
MiR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects
- 29 Jul 2026
- Theranostics
A mechanobiology-driven cell-derived ECM bioink for engineering 3D glioblastoma tumor microenvironment models
- 29 Jul 2026
- Theranostics
Magnetofection-mediated siRNA delivery ameliorates cartilage damage in Kashin-Beck disease via targeting SIRT3 and protecting primary cilia
- 22 Jul 2026
- Theranostics
Clinically accessible drug-based nano-assemblies with self-targeting ability for NIR-II fluorescence imaging-guided surgery in triple-negative breast cancer
- 22 Jul 2026
- Theranostics
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagy
- 22 Jul 2026
- Theranostics
Multifunctional nanozyme platforms in central nervous system therapies: from rational design to translational medicine
- 29 Jul 2026
- Theranostics
MiR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects
- 29 Jul 2026
- Theranostics
A mechanobiology-driven cell-derived ECM bioink for engineering 3D glioblastoma tumor microenvironment models
- 29 Jul 2026
- Theranostics
Magnetofection-mediated siRNA delivery ameliorates cartilage damage in Kashin-Beck disease via targeting SIRT3 and protecting primary cilia
- 22 Jul 2026
- Theranostics
Clinically accessible drug-based nano-assemblies with self-targeting ability for NIR-II fluorescence imaging-guided surgery in triple-negative breast cancer
- 22 Jul 2026
- Theranostics
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagy
- 22 Jul 2026
- Theranostics
FAQs on Theranostics
How long has Theranostics been actively publishing? 
What is the publishing frequency of Theranostics?
How many articles did Theranostics publish last year?
What is the eISSN & pISSN for Theranostics?
What is Citescore for Theranostics?
What is SNIP score for Theranostics?
What is the SJR for Theranostics?
Who is the publisher of Theranostics?
